Cargando…
The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer
We retrospectively reviewed outcomes of treatments with cisplatin and topotecan in patients with previously-treated uterine cervix cancer. We analyzed the medical records of patients with advanced (stage IVB) or recurrent or persistent squamous or non-squamous cell carcinoma of the cervix, who were...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902288/ https://www.ncbi.nlm.nih.gov/pubmed/29620661 http://dx.doi.org/10.1097/MD.0000000000010340 |